Page last updated: 2024-11-02

pamidronate and Colonic Neoplasms

pamidronate has been researched along with Colonic Neoplasms in 2 studies

Colonic Neoplasms: Tumors or cancer of the COLON.

Research Excerpts

ExcerptRelevanceReference
"Hypercalcemia was induced either by sc inoculation of syngeneic colon (C-26) adenocarcinoma cells or by sc injection of high-dose recombinant PTHrP (0."1.33The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy. ( Adamu, S; Asuncion, F; Capparelli, C; Dunstan, CR; Geng, Z; Grisanti, M; Kostenuik, PJ; Morony, S; Starnes, C; Tan, HL; Warmington, K; Weimann, B, 2005)
"Pamidronate (APD) is a new drug in the treatment of osteolytic bone diseases."1.29Cytotoxic effects of pamidronate on monolayers of human intestinal epithelial (Caco-2) cells and its epithelial transport. ( Brill, H; de Water, R; den Hartigh, J; Ramp-Koopmanschap, W; Sparidans, R; Twiss, IM; Vermeij, P; Wijdeveld, M, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morony, S1
Warmington, K1
Adamu, S1
Asuncion, F1
Geng, Z1
Grisanti, M1
Tan, HL1
Capparelli, C1
Starnes, C1
Weimann, B1
Dunstan, CR1
Kostenuik, PJ1
Twiss, IM1
de Water, R1
den Hartigh, J1
Sparidans, R1
Ramp-Koopmanschap, W1
Brill, H1
Wijdeveld, M1
Vermeij, P1

Other Studies

2 other studies available for pamidronate and Colonic Neoplasms

ArticleYear
The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy.
    Endocrinology, 2005, Volume: 146, Issue:8

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bone Resorption; Calcium; Carrier Proteins; Cell Lin

2005
Cytotoxic effects of pamidronate on monolayers of human intestinal epithelial (Caco-2) cells and its epithelial transport.
    Journal of pharmaceutical sciences, 1994, Volume: 83, Issue:5

    Topics: Biological Transport; Cell Line; Cell Membrane Permeability; Colonic Neoplasms; Diphosphonates; Dose

1994